This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beth Israel Deaconess Medical Center, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Cliona O'Farrelly: Innovator in Metabolic Disorder Treatments
Introduction
Cliona O'Farrelly is a prominent inventor based in Wexford, Ireland. She has made significant contributions to the field of medical research, particularly in the treatment of metabolic disorders. Her innovative work has the potential to impact the lives of many individuals suffering from conditions such as obesity and diabetes.
Latest Patents
Cliona O'Farrelly holds a patent for "Methods and compositions for treatment of metabolic disorders." This invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders. The patent features methods, kits, and compositions for the treatment of such disorders by administering a composition capable of increasing iNKT activity. She has 1 patent to her name.
Career Highlights
Cliona O'Farrelly is affiliated with Beth Israel Deaconess Medical Center, Inc., where she conducts her research. Her work is recognized for its innovative approach to addressing complex health issues.
Collaborations
Some of her notable coworkers include Donal O'Shea and Mark A Exley. Their collaborative efforts contribute to advancing research in metabolic disorders.
Conclusion
Cliona O'Farrelly's contributions to the field of metabolic disorder treatments highlight her role as an influential inventor. Her innovative approaches and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile